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Background: Small supernumerary marker chromosomes (sSMCs) are additional, structurally abnormal chromosomes,
generally smaller than chromosome 20 of the same metaphase spread. Due to their small size, they are difficult to
characterize by conventional cytogenetics alone. In regard to their clinical effects, sSMCs are a heterogeneous group: in
particular, sSMCs containing pericentromeric euchromatin are likely to be associated with abnormal outcomes,
although exceptions have been reported. To improve characterization of the genetic content of sSMCs, several
approaches might be applied based on different molecular and molecular-cytogenetic assays, e.g., fluorescent in situ
hybridization (FISH), array-based comparative genomic hybridization (array CGH), and multiplex ligation-dependent
probe amplification (MLPA).
To provide a complementary tool for the characterization of sSMCs, we constructed and validated a new, FISH-based,
pericentromeric Bacterial Artificial Chromosome (BAC) clone set that with a high resolution spans the most proximal
euchromatic sequences of all human chromosome arms, excluding the acrocentric short arms.
Results: By FISH analysis, we assayed 561 pericentromeric BAC probes and excluded 75 that showed a wrong
chromosomal localization. The remaining 486 probes were used to establish 43 BAC-based pericentromeric panels.
Each panel consists of a core, which with a high resolution covers the most proximal euchromatic ~0.7 Mb (on
average) of each chromosome arm and generally bridges the heterochromatin/euchromatin junction, as well as
clones located proximally and distally to the core. The pericentromeric clone set was subsequently validated by
the characterization of 19 sSMCs. Using the core probes, we could rapidly distinguish between heterochromatic
(1/19) and euchromatic (11/19) sSMCs, and estimate the euchromatic DNA content, which ranged from approximately
0.13 to more than 10 Mb. The characterization was not completed for seven sSMCs due to a lack of information about
the covered region in the reference sequence (1/19) or sample insufficiency (6/19).
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Conclusions: Our results demonstrate that this pericentromeric clone set is useful as an alternative tool for sSMC
characterization, primarily in cases of very small SMCs that contain either heterochromatin exclusively or a tiny
amount of euchromatic sequence, and also in cases of low-level or cryptic mosaicism. The resulting data will
foster knowledge of human proximal euchromatic regions involved in chromosomal imbalances, thereby improving
genotype–phenotype correlations.
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Small supernumerary marker chromosomes (sSMCs) are
additional centric chromosomal segments that are difficult
to characterize by conventional cytogenetics alone due to
their small size [1]. Excluding the sSMCs associated
with five well-known syndromes (Pallister-Killian, iso-
dicentric chromosome 15q [2], isochromosome 18p,
Cat Eye [i(22p ~ q)], and derivative chromosome 22
[der(22)t(11;22)] syndromes [1]), the overall risk for a
pathological phenotype in prenatal de novo cases is
26–30% [3].
The phenotypic expression of sSMCs ranges from
asymptomatic to symptomatic, and depends on several
factors including chromosomal origin, satellite vs. non-
satellite inclusion, euchromatic/heterochromatic con-
tent, uniparental disomy (UPD) of the chromosomes
homologous to the sSMC, and mosaicism [3]. Further-
more, the presence of centromere-proximal euchroma-
tin on an sSMC correlates with abnormal phenotypes,
although several exceptions have been described [4].
Since the optimal strategies for genetic counseling and
clinical management depend on the characteristics of
sSMCs, it is vitally important to precisely characterize
sSMCs in order to obtain additional information regarding
their phenotypic effects. To this end, several fluorescent in
situ hybridization (FISH)-based techniques have been
developed over the years [5] for determining the origin
of sSMCs and allowing breakpoint characterization, at
least in cases of larger euchromatic SMCs. These methods
include multicolor FISH (M-FISH) [6], spectral karyotyp-
ing (SKY) [7], centromere- and subcentromere-specific
M-FISH (cenM-FISH and subcenM-FISH) [3,8,9], multi-
color banding [10], and microdissection followed by
reverse FISH [11,12]. More recently, a pericentric-ladder-
FISH (PCL-FISH) probe set has been developed based on
174 locus-specific BAC probes, and this probe set has
been used in dual-color/multicolor–FISH approaches.
This tool is specific for the pericentromeric regions and,
therefore, enables sSMC breakpoint characterization with
a resolution between 1 and ~10 Mb [13].
Furthermore, array-based comparative genomic hybridization
(array CGH) analysis has been extensively used in
sSMC characterization. This method allows, in a singleexperiment, determination of the marker chromosomal
origin, definition of the size of aberrations (including
euchromatic regions), and identification of complex re-
arrangements or multiple markers in single individuals
[14-20]. However, array CGH may fail to identify the
origins of very small SMCs in up to 50% of cases be-
cause its pericentromeric coverage is limited to the
presence of segmental duplications, and it may also be
unable to detect low-level and cryptic mosaicism
[13,19-21]. Consequently, it is necessary to comple-
ment array CGH using FISH approaches [13,22]. In
addition, to allow rapid discrimination between sSMCs
that are positive or negative for unique sequences, an al-
ternative approach using multiplex ligation-dependent
probe amplification (MLPA) analysis has recently been
developed for use in the context of prenatal diagnosis [23].
In this study, we report the design and validation of a
new pericentromeric Bacterial Artificial Chromosome
(BAC) clone set that covers the most proximal euchro-
matic sequences of all human chromosome arms, as well
as the heterochromatin/euchromatin junctions, exclud-
ing the short arms of acrocentric chromosomes. This set
was designed to improve molecular characterization of
sSMCs by FISH analysis, a molecular-cytogenetic tech-
nique that, in contrast to array CGH, is available in most
cytogenetic laboratories. This new complementary tool
will be especially useful in cases of low-level mosaicism
and/or very small marker chromosomes, which are likely
to consist entirely of heterochromatin or contain only a
tiny amount of euchromatic sequence, as demonstrated
by some reported sSMC cases.
Results
Setting up 43 pericentromeric BAC probe panels
Using FISH analysis, we assayed 561 pericentromeric
BAC probes, of which 323 (57.6%) were specific, 163
(29.0%) exhibited multiple cross-hybridizations, and 75
(13.4%) were excluded because of a wrong chromosomal
localization. We then established 43 pericentromeric
panels (excluding the acrocentric p arms), each of which
consists of a high resolution core panel, which bridges the
heterochromatin/euchromatin junction and usually com-
prises 3–7 contiguous or very close clones, as well as
Castronovo et al. Molecular Cytogenetics 2013, 6:45 Page 3 of 12
http://www.molecularcytogenetics.org/content/6/1/45clones located proximally and distally to the core
(Additional file 1: Table S1). The core panels were
completed for 35 chromosome arms (2p, 2q, 3p, 3q,
4p, 4q, 5p, 5q, 6p, 6q, 7p, 7q, 8p, 8q, 9q, 10p, 11q, 12p,
12q, 13q, 14q, 15q, 16p, 16q, 17p, 17q, 18p, 18q, 19p,
19q, 20p, 22q, Xp, Xq, and Yq); they span, generally in
a continuum, the proximal ~0.73 Mb (on average) of
each chromosome arm (Table 1). A core panel for
chromosome Yp was not established because of the
lack of a physical map in the reference sequence,
whereas the core panels of seven other chromosome
arms were incomplete due to either the lack of a het-
erochromatin/euchromatin junction in the reference
sequence (1p, 10q, 11p, 20q, and 21q), or the presence
of pericentromeric paralogous segmental duplications
(1q and 9p) that prevented us from obtaining unique
mapping information (Table 1 and Additional file 1:
Table S1).
Molecular-cytogenetic characterization of 19 sSMCs
The utility of the clone set was then validated by the mo-
lecular characterization of 19 sSMCs, six of which were
ascertained during routine prenatal testing (Additional file 2:
Table S2). Nine sSMCs (~47%) were derived from acrocen-
tric chromosomes, six (~32%) were inherited (patients 6, 8,
10–13), of which two were detected in two siblings (patients
10 and 11) and are complex marker chromosomes originat-
ing from a maternal balanced rearrangement. Multiple
markers occurred in a single adult patient (5%) (patient 15).
Mosaicism was detected in seven patients (~37%) (patients
1–5, 15, and 18), in most cases involving non-acrocentric
chromosomes. Uniparental disomy (UPD) analysis of sSMC
sister chromosomes was not performed. Details of sSMC
characterization are provided in Additional file 2: Table S2.
Using the core panel probes, we were able to rapidly dis-
tinguish between heterochromatic (1/19) and pericentro-
meric euchromatic marker chromosomes (11/19), even in
cases of low-level mosaicism. In addition, we either pre-
cisely established or estimated the size of the euchromatic
content in 17 out of 19 sSMCs (Additional file 2: Table S2,
Figures 1, 2 and 3). The euchromatic DNA present on
the sSMCs ranged from ~0.13 Mb to more than 10 Mb
(Additional file 2: Table S2). However, sSMC characterization
was not completed in patient 6, due to the incompleteness
of the chromosome 21q core panel physical map in the ref-
erence sequence, and in patients 7–11 and 15, due to sample
insufficiency (Additional file 2: Table S2).
In two patients, we detected large marker chromosomes
in high-level mosaicism, as follows: a ring chromosome 4
[r(4)] in patient 3, and an r(11) in patient 5 (Additional
file 2: Table S2, Figure 2). The molecular characterization
of these SMCs was performed using the panel probes
and subsequently refined by array CGH analysis, which
allowed a more precise definition of the breakpoints.In particular, the chromosome 4p breakpoint was mapped
between BAC probes RP11-89F4 and RP11-178N2
(chr4:44,621,297 − 45,736,237, hg19) (Figure 2B), and
then narrowed down by array CGH to a 236 kb re-
gion between oligonucleotide probes A_14_P127561
and A_14_P128650 (chr4:45,518,972 − 45,754,992, hg19);
thus, the breakpoint was mapped at ~45.5–45.7 Mb
from the 4p telomere (chr4:45,518,972–45,736,237, hg19)
(Additional file 2: Table S2, Figure 2A). Similarly, the 4q
breakpoint was mapped between BACs RP11-91C3
(Figure 2C) and RP11-63E13 (chr4:61,086,318–66,600,553,
hg19), and the position was then refined to a location be-
tween oligonucleotides A_14_P137150 and A_14_P133582
(chr4:61,126,608–61,343,360, hg19) (Additional file 2:
Table S2, Figure 2A). For sSRC(11), the 11p breakpoint
was mapped between BACs RP11-1062A8 and RP11-
746P9 (chr11:49,259,387–50,111,641, hg19) (Figure 2E),
and then refined between oligonucleotides A_14_P126799
and A_14_P134986 (chr11:49,919,441–50,378,743, hg19);
thus, this breakpoint mapped precisely at 49.9 − 50.1 Mb
from the 11p telomere (chr11:49,919,441–50,111,641,
hg19) (Additional file 2: Table S2, Figure 2D). The 11q
breakpoint was characterized only by array CGH be-
cause the 11q panel probes were not informative due
to their proximal position (Additional file 2: Table S2,
Figure 2D,F). No further cryptic genomic imbalances
were detected in either patient.
Discussion
Pericentromeric regions of human chromosomes are tran-
sitional territories between centromeric heterochromatin
and euchromatic regions. They represent complex mosaic
structures, including coding sequences interspersed with
non-coding sequences [24]. Therefore, sequencing of
these regions is technically difficult, and a complementary
approach is necessary to clarify their role in human
disease.
sSMCs generally contain a centromeric/pericentromeric
region, and their precise characterization is a powerful
tool for identifying which genomic regions lead to abnor-
malities when they are affected by dosage imbalances.
Over the years, numerous FISH-based approaches have
been developed, and these methods have contributed to
improvements in sSMC characterization. However, assays
such as M-FISH/SKY [6,7], cenM-FISH [8] and subcenM-
FISH [3,9] are limited to the identification of the sSMC
chromosomal origin or the characterization of larger
euchromatic SMCs, and only the use of FISH-banding or
locus-specific probes [13,25,26] can improve breakpoint
characterization [13,27,28]. In particular, the PCL-FISH
probe set, recently developed by Hamid et al., (2012) [13],
is a bar-code FISH assay that constitutes a 10 Mb raster
along pericentromeric chromosomal regions, allowing
the determination of mosaic and non-mosaic sSMC










to the core panel
Distance between heterochromatic
region and proximal euchromatic
core BAC clone (Mb)b
Distal euchromatic
BAC clone belonging
to the core panel
Distance between proximal
and distal euchromatic core
BAC clones (Mb)c
1pd 121.5 RP11-803J8 at 1p11.2 0.015 CTD-3138A9 at 1p12-p11.2 0.98
1qd 142.6 RP11-15M9 at 1q21.1 0.76 CTD-2326L14 at 1q21.1 1.46
2p 90.5 CTD-2269O20 at 2p11.2-p11.1 0 RP11-1023H22 at 2p11.2 0.61
2q 96.8 RP11-139J5 at 2q11.1-q11.2 0 RP11-245P4 at 2q11.2 0.96
3p 87.9 RP11-424C9 at 3p11.2-p11.1 0 RP11-598A10 at 3p12.1-p11.2 0.71
3q 93.9 RP11-259L20 at 3q11.1-q11.2 0 RP11-625F19 at 3q11.2 0.87
4p 48.2 RP11-260K18 at 4p12-p11 0 CTD-2057N12 at 4p12 0.88
4q 52.7 RP11-98B6 at 4q11-q12 0 RP11-600M5 at 4q12 0.76
5p 46.1 RP11-10F16 at 5p12-p11 0 RP11-134N5 at 5p12 0.91
5q 50.7 RP11-463E10 at 5q11.1-q11.2 0 CTD-3113M11 at 5q11.2 0.33
6p 58.7 RP11-136G2 at 6p11.2-p11.1 0 RP11-799H20 at 6p11.2 1.02
6q 63.3 RP11-448N11 at 6q11.1-q11.2 0 RP11-78B14 at 6q12 0.30
7p 58.0 CTD-2593N8 at 7p11.2-p11.1 0 RP11-114G11 at 7p11.2 0.66
7q 61.7 CTD-2245O1 at 7q11.1-q11.21 0 RP11-45N18 at 7q11.21 0.84
8p 43.1 RP11-73M19 at 8p11.21-p11.1 0 RP11-577C12 at 8p11.21 0.79
8q 48.1 CTD-2563N10 at 8q11.1-q11.21 0 RP11-367A12 at 8q11.21 0.56
9pd 47.3 RP11-606B18 at 9p11.2 0.37 RP11-361G22 at 9p11.2 0.64
9q 65.9 CTD-2508M5 at 9q12-q13 0 CTD-2050L17 at 9q13 0.49
10p 38.0 CTD-3195G22 at 10p11.21-p11.1 0 RP11-739D18 at 10p11.21 0.58
10qd 42.3 RP11-80L2 at 10q11.21 0.08 RP11-351D16 at 10q11.21 1.32
11pd 51.6 RP11-100E23 at 11p11.12 0.06 RP11-318O24 at 11p11.12 1.00
11q 55.7 CTD-3202L3 at 11q11-q12.1 0 RP11-720L5 at 11q12.1 0.85
12p 33.3 RP11-460N10 at 12p11.21-p11.1 0 RP11-8P13 at 12p11.21 0.48
12q 38.2 RP11-496H24 at 12q11-q12 0 RP11-715M8 at 12q12 0.68
13q 19.5 RP11-294G16 at 13q11-q12.11 0 RP11-71I1 at 13q12.11 0.32
14q 19.1 RP11-639F13 at 14q11.1-q11.2 0 RP11-77E23 at 14q11.2 0.90
15q 20.7 RP11-108C1 at 15q11.1-q11.2 0 RP11-666L22 at 15q11.2 0.34
16p 34.6 RP11-488I20 at 16p11.2-p11.2 0 RP11-1088B6 at 16p11.2 0.32
16q 47.0 RP11-627O2 at 16q11.2-q12.1 0 RP11-671L23 at 16q12.1 0.36
17p 22.2 RP11-718K3 at 17p11.2-p11.1 0 RP11-937K3 at 17p11.2 0.51

















Table 1 Pericentromeric euchromatic coverage of the high-resolution BAC-based core panels (Continued)
18p 15.4 RP11-1133K23 at 18p11.21-p11.1 0 RP11-1025M21 at 18p11.21 0.52
18q 19.0 RP11-746M23 at 18q11.1-q11.2 0 RP11-60G3 at 18q11.2 0.66
19p 24.4 RP11-350E11 at 19p12-p11 0 RP11-642I13 at 19p12 0.86
19q 28.6 CTD-2045N7 at 19q11-q12 0 RP11-347I6 at 19q12 0.95
20p 25.6 RP11-161K13 at 20p11.21-p11.1 0 RP11-156D15 at 20p11.21 0.49
20qd 29.4 CTD-2311M18 at 20q11.21 0.02 RP11-1147I19 at 20q11.21 1.17
21qd 14.3 RP11-203F20 at 21q11.2 0.13 RP11-1025M7 at 21q11.2 0.93
22q 17.9 RP11-958H20 at 22q11.1-q11.21 0 RP11-81B3 at 22q11.21 0.71
Xp 58.1 CTD-2225J11 at Xp11.21-p11.1 0 RP11-936C8 at Xp11.21 0.96
Xq 63.0 RP11-943J20 at Xq11.1-q11.2 0 RP11-284B18 at Xq11.2 0.54
Ype 11.6 RP11-108I14 at Yp11.2 1.50
Yq 13.4 RP11-1100G7 at Yq11.1-q11.21 0 RP11-91N9 at Yq11.21 1.1
aThe location of the heterochromatic region is an approximation taken from the February 2009 release of the UCSC Human Genome Browser Database, which indicates the distance from the most distal available p-
arm sequence to the centromere start and end for that chromosome. For chromosomes 1q, 9q, and 16q, the heterochromatic region ending position indicates the telomeric border of the heterochromatic bands 1q12,
9q12, and 16q11.2, respectively.
bThe distance between the heterochromatic region and the most proximal available euchromatic BAC clone indicates the starting position of the pericentromeric coverage of the BAC core panel for each
chromosome arm.
cThe distance between the proximal and distal euchromatic core BAC clones indicates the pericentromeric euchromatic coverage of the core panel for each chromosome arm; if the proximal BAC clone overlaps with
heterochromatin/euchromatin bridge, the distance refers only to the euchromatic sequence.
dThe core panels of chromosomes 1p, 10q, 11p, 20q, and 21q were not completed because of the lack of heterochromatin/euchromatin-bridging physical maps in the reference sequence. The core panels of
chromosomes 1q and 9p are incomplete due to the presence of pericentromeric paralogous segmental duplications; therefore, the corresponding core panel probes were excluded from the clone set because their
hybridization signals do not give unique mapping information. The partial core panel of chromosome 10q was established using non-contiguous clones.

















Figure 1 FISH characterization of sSRC(10) of patient 4 (A, B) and sSRC(16) of patient 14 (C, D), including breakpoint mapping and
sizing of the euchromatic region. (A) Partial metaphase hybridized with the 10p11.23 BAC probe RP11-39E10, showing signals on both
chromosome 10 homologs and the der(10) marker chromosome (arrow). (B) Partial metaphase hybridized with the BAC probe RP11-178A10 at
10q11.21, showing a diminished hybridization signal on the der(10) marker chromosome (arrow) relative to the chromosome 10 homologs. (C and D)
Partial metaphases hybridized with the BAC probes RP11-488I20 at 16p (C) and CTD-2382P11 at 16q (D), showing signals on the chromosome
16 homologs but not sSRC(16) (arrows).
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size. In addition, this approach has been particularly
useful in characterizing cryptic mosaic sSMCs [29], and
for easily defining all involved breakpoints [13]. However,
because it covers the most proximal 1 Mb of euchromatic
sequences of each chromosome arm with a very low reso-
lution, PCL-FISH is not useful for the characterization of
very small SMCs that contain only tiny amounts of eu-
chromatic sequence [13]. Likewise, a more sensitive tech-
nique such as array CGH, which can significantly narrow
down sSMC breakpoints [14-20,30], can still yield incom-
plete pericentromeric coverage due to the presence of
large duplicated sequences. Moreover, array CGH cannot
detect low-level and/or cryptic mosaic sSMCs.
Therefore, in order to provide a complementary tool
for sSMC characterization, we established a FISH-based
pericentromeric BAC clone set, including probes that
cover the most proximal euchromatic ~0.7 Mb (on aver-
age) of each chromosome arm at a high resolution. The
pericentromeric probe set also includes probes that
bridge the heterochromatin/euchromatin junctions (Table 1
and Additional file 1: Table S1), enabling rapid discrimin-
ation between euchromatic (11/19 in the present series)
and heterochromatic (1/19) sSMCs, irrespective of marker
chromosome origin (Additional file 2: Table S2). The most
proximal probes were chosen independently of the presence
of segmental duplications, with the exceptions of chro-
mosomes 1q and 9p, where pericentromeric paralogoussegmental duplications have been detected. As expected, a
significant percentage of the assayed probes (~13%) were
mislocalized, supporting the need for the large screening
effort we performed to verify the predicted physical position
of each clone. As previously reported for PCL-FISH [13],
we confirmed the utility of our new BAC-probe set in
characterizing low-level mosaic sSMCs (Additional file 2:
Table S2), suggesting that this approach could be applied
to breakpoint identification in cases of cryptic mosaic
sSMCs; however, no pertinent cases are present in the
series reported here.
In terms of genotype–phenotype correlation, the data
we collected regarding sSMC characterization allowed
us to confirm the existence of pericentromeric euchro-
matic critical and noncritical regions surrounding the
centromeres of all chromosome arms, i.e., regions in
which trisomy or tetrasomy either does or does not
correlate with pathological phenotypes [4]. Accordingly,
we declare no clinical signs reported in association with
acrocentric sSMCs that have breakpoints localized in pre-
dicted pericentromeric noncritical regions [4,14,16,22,31]
(patients 6–9, 12, and 13), with the exception of patient 7,
who exhibited a growth delay likely not associated with
the sSMC (Additional file 2: Table S2). Furthermore, in
siblings 10 and 11, the 14q breakpoint characterization
was useful in linking the reported clinical findings specific-
ally to trisomy of 6pter-p25 (Additional file 2: Table S2).
By contrast, we classified the larger idic(22;22) marker
Figure 2 Combined array-CGH and FISH characterization of SRC(4) of patient 3 (A-C) and SRC(11) of patient 5 (D-F). Upper row:
(A) Identification of a heterozygous duplication of 15.4 Mb (chr4:45,754,992–61,126,608, hg19) using array CGH (Agilent 4 × 44K) in patient 3.
The BAC probes RP11-178N2 at 4p12 (B) and RP11-91C3 at 4q13.1 (C) produce hybridization signals on both chromosomes 4 and the SRC(4).
Bottom row: (D) Identification of a heterozygous duplication of 13.4 Mb (chr11:50,378,743–63,743,029, hg19) using array CGH (Agilent 4 × 44K) in patient
5. The BAC probes RP11-746P9 at 11p11.12 (E) and RP11-872D17 at 11q12 (F) produce hybridization signals on both chromosomes 11 and the SRC(11).
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Syndrome (CES) chromosomes, which results in the CES
phenotype [32], as confirmed in patient 17 (Additional
file 2: Table S2). In addition, in patient 18, the molecular
characterization of idic(22;22) revealed asymmetrical
breakpoints that resulted in both a tetrasomy of ~750 kb,
which featured the gap reported between the end of the
noncritical region and the start of the critical region [4],
and a trisomy of ~150–400 kb of euchromatic sequencesthat are included within the 22q predicted critical region
[4] (Additional file 2: Table S2, Figure 3E,F). These obser-
vations suggest that the mild phenotype of patient 18,
relative to the classical CES clinical presentation, can be at
least partially attributed to trisomy rather than tetrasomy
of the same euchromatic region, combined with low-level
mosaicism of sSMC(22) (Additional file 2: Table S2).
Among the non-acrocentric marker chromosomes col-
lected in our series, the SMC characterization revealed
Figure 3 FISH characterization of sSMC(2) and sSMC(18) of patient 15 (A-D), and sSMC(22) of patient 18 (E, F). (A) Partial metaphase
hybridized with the BAC probe RP11-749K13 at 18p11.21 (red), showing a hybridization signal on idic(18;18) marker chromosomes (white arrow)
that is enlarged relative to those on chromosome 18 homologs, as well as cross-hybridization signals on the der(2) marker chromosome (green
arrow) and chromosome 2 homologs. The BAC probe RP11-1069D4 at 2p11.1 (blue) produces hybridization signals on der(2) marker chromosome
(green arrow) and chromosome 2 homologs. (B) Partial metaphase hybridized with the BAC probe RP11-1035O2 at 18q11.1 does not show a
hybridization signal on idic(18;18) (white arrow). (C) Partial metaphase hybridized with the BAC probe RP11-134N21 at 2q11.1, which is deleted
on der(2) (green arrow), showing cross-hybridization signals on both idic(18;18) (white arrow) and chromosome 18 homologs. (D) Partial metaphase
hybridized with the BAC probe RP11-71B7 at 2q11.1, showing a hybridization signal on der(2) (green arrow) and on chromosome 2 homologs.
(E) Metaphase hybridized with the BAC probes RP11-1053O2 at 22q11.21 shows an equal signal on the idic(22;22) marker chromosome (arrow) relative
to the signals on the chromosome 22 homologs. (F) Metaphase hybridized with the BAC probe RP11-690P21 at 22q11.21 shows a diminished signal
on the idic(22;22) marker chromosome (arrow) relative to the signals on the chromosome 22 homologs.
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in two cases [4,14-16,20,22,33,34], consistent with the
observation that the corresponding patients (3 and 15)had normal phenotypes (Figures 2A–C and 3A–D,
Additional file 2: Table S2). Notably, the association of
sSMC(2) and sSMC(18) observed in patient 15 has not
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we identified pericentromeric segmental duplications
shared by chromosomes 2 and 18 (Figure 3A–D), and
hypothesized that a complex genomic rearrangement
had occurred between those two chromosomes, result-
ing in sSMC formation and in the simultaneous dele-
tion of the sequence covered by probe RP11-134N21
from sSMC(2) (Figure 3D, Additional file 2: Table S2).
In regard to pathological non-acrocentric sSMCs, our
molecular characterization helped us to either refine or
confirm the boundaries of the predicted critical regions
and to improve genotype–phenotype correlations. For
example, characterization of patient 2’s mosaic sSRC(1)
indicated possible trisomy of 1p12–q21.1 chromosomal
region, involving at most ~1.91 Mb of euchromatic se-
quences at 1q21.1 (Additional file 2: Table S2). Although
the boundaries between the critical and noncritical
regions on 1q are not yet available [4], we propose that
trisomy of 1q21.1 might be responsible for patient 2’s
phenotype (Additional file 2: Table S2), as suggested by
previous data [3,9,35-38]. However, neurological abnor-
malities like those exhibited by our patient have been
previously reported in patients carrying mosaic sSMC
(1), resulting in trisomy of the 1p12–q12 region. In those
cases, the 1q breakpoints were mapped within the 1q12
heterochromatic region, suggesting that the 1p trisomy
was responsible for the pathological phenotype [3,8,9,39].
Both breakpoints of patient 5’s SRC(11) were inferred
to have occurred in the pericentromeric critical regions,
leading to mosaic trisomy of the 11p11.12–q13.1 region
(Additional file 2: Table S2, Figure 2E,F). To date, only
one patient (11-W-p11.12/3-1 in the sSMC database [4])
has been reported to have a mosaic sSRC(11) character-
ized by breakpoints mapped within the same chromo-
somal bands found in our patient [4]. The reported
pathological clinical presentation, characterized by dys-
morphism and severe developmental delay, resembles
that observed in patient 5 (Additional file 2: Table S2),
confirming the pathogenetic role of mosaic trisomy of
11p11.12–q13.1.
Finally, sSMC(10) of patient 4 and sSRC(16) of patient
14 were both ascertained during prenatal testing. The
sSRC(16) exclusively involved centromeric heterochro-
matin (Additional file 2: Table S2, Figure 1C, D), leading
the parents to continue the pregnancy, which ended
with the birth of a normal baby. By contrast, the sSMC
(10) resulted in mosaic trisomy of the 10p11.23–q11.21
region (Additional file 2: Table S2, Figure 1A,B). We
considered that a pathological phenotype might arise due
to trisomy of at least 3.6 Mb of 10p proximal euchromatic
sequences because the 10q breakpoint mapped in the
predicted noncritical region [4,17,40]. This hypothesis was
subsequently confirmed by the patient’s neonatal pheno-
type (Additional file 2: Table S2).Conclusions
To summarize, our data demonstrate the potential value
of our pericentromeric clone set for characterization of
sSMCs in both prenatal and postnatal diagnostics. Due
to the fact that the established resource covers all avail-
able pericentromeric regions, it may be particularly use-
ful in cases of very small marker chromosomes, allowing
rapid discrimination between heterochromatic and eu-
chromatic sSMCs, as well as precise sizing of imbal-
ances. We also demonstrated the complementarity of
FISH analysis using the pericentromeric clone set with
array CGH analysis in the characterization of large
marker chromosomes.
Apart from ad hoc combinations of different methods,
performed when requested, FISH analysis is currently
the only available technique for analyzing sSMCs in low
or cryptic mosaicism. However, to use this probe set in
prenatal cases, cytogenetic labs need to have sufficient
resources to store the BAC clones and prepare the
probes within a short time. Therefore, although applica-
tion of this tool in prenatal diagnosis would be benefi-
cial, we strongly recommend that it is used in research
aimed at increasing our knowledge of the imbalances of
human proximal euchromatic regions, thereby improving
genotype–phenotype correlations and the assessment of
the genetic risks of supernumerary marker chromosomes.
Methods
sSMC samples
Chromosomal samples from peripheral blood lympho-
cytes and amniotic fluid were collected from five cyto-
genetic labs. All samples were previously karyotyped by
conventional cytogenetics (Q- or G-banding), and the
sSMC origin was previously identified by FISH analysis
using commercial centromere-specific probes (Vysis,
Maidenhead, UK), following the manufacturer’s instruc-
tions. In both cases, at least 16 metaphases were analyzed.
FISH analysis
RPCI-11 and CTD BAC clones covering the pericen-
tromeric genomic regions of human chromosome arms
were selected by consulting the UCSC Genome Browser
Database (http://genome.cse.ucsc.edu, hg19, February 2009).
Clones were provided by Prof. Mariano Rocchi, University of
Bari (IT) and Invitrogen (Carlsbad, CA, USA). The probes’
physical positions were verified on a few control metaphases
derived from peripheral blood lymphocytes. All probes were
labeled by nick-translation with biotin (Hoffman-La Roche,
Basel, Switzerland), digoxigenin (Hoffman-La Roche), or Cy3
(Amersham Biosciences, Chalfont St. Giles, UK), and
then visualized using FITC–anti-digoxigenin antibodies
(Hoffman-La Roche) or streptavidin-DEAC (Sigma-Aldrich,
St. Louis, MO, USA). Image acquisition was performed on a
Leica DMRA2 fluorescence microscope (Leica, Wetzlar,
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FITC, Cy3, and DEAC. Images were acquired using a
charge-coupled device (CCD) camera (Leica) with a magnifi-
cation factor of 100×. Image analysis was performed using
the Leica CW4000-FISH software (version Y1.3.1). In the ini-
tial step of sSMC characterization, the most proximal avail-
able core probe(s) for the involved chromosome arm(s) was
used to discriminate between euchromatic and heterochro-
matic sSMCs. Next, fine breakpoint mapping was performed
using clones within and/or distal to the core panels, depend-
ing on sSMC size. A single-color, dual-color, or three-color
hybridization approach was chosen depending on the avail-
able amount of sSMC sample and the time available to
complete the analysis. In case of non-mosaic sSMCs, at least
16 metaphases were analyzed, whereas in cases of mosaic
sSMCs, the number of analyzed metaphases decreased pro-
portionally with the level of mosaicism. The FISH protocols
of Lichter et al. [41] and Lichter and Cremer [42] were
followed, with minor modifications.
Array CGH analysis
Array CGH analysis was performed using the Human
Genome CGH Microarray Kit 4 × 44K (Agilent Technologies,
Palo Alto, CA), which consists of 42,494 60-mer
oligonucleotide probes covering the entire genome
with an average spatial resolution of ~43 kb. From both test
and sex-matched reference (Promega, Southampton, UK)
samples, 3 μg of genomic DNA, previously extracted from
probands’ whole blood using the GenEluteTM Blood
Genomic DNA kit (Sigma-Aldrich), was processed
according to the manufacturer’s protocol. Images were
obtained using the Agilent Feature Extraction software
(version 9.1), and chromosomal profiles were obtained
using the ADM-2 algorithm provided by DNA Analytics
software (v4.0) (Agilent Technologies).
Consent
Written informed consent to the research investigation,
which was approved by the Ethical Clinical Research
Committee of Istituto Auxologico Italiano, was obtained
from either the adult patients or one of the parents in
case of child patients.
Additional files
Additional file 1: Table S1. Detailed list of the collected 486
pericentromeric BAC probes, including the 214 clones which belong to
the high-resolution core panels, according to the UCSC Genome Browser
Database assembly hg19.
Additional file 2: Table S2. Summary of 19 sSMCs characterized using the
pericentromeric BAC clone set, including clinical data of the carrying patients.
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